Rapid decrease in titer and breadth of neutralizing anti-HCV antibodies in HIV/HCV-coinfected patients who achieved SVR
Author
Vigón, Lorena; Vázquez Morón, Sonia; Berenguer, Juan; González García, Juan; Jiménez Sousa, María Angeles; Guardional, Josep M.; Crespo, Manuel; Santos Gil, Ignacio de los; Von Wichmann, Miguel A.; Carrero, Ana; Yélamos, María Belén; Gómez, Julián; Resino, Salvador; Martínez, Isidoro; The GESIDA 3603b Cohort Study GroupEntity
UAM. Departamento de MedicinaPublisher
Nature ResearchDate
2019-08-21Citation
10.1038/s41598-019-48592-5
Scientific Reports 9 (2019): 12163
ISSN
2045-2322DOI
10.1038/s41598-019-48592-5Funded by
This study was supported by grants from Instituto de Salud Carlos III (ISCIII; grant numbers PI14/01094 and PI17/00657 to JB, PI17/00903 to JGG, PI14CIII/00011 and PI17CIII/00003 to SR) and Ministerio de Sanidad, Servicios Sociales e Igualdad (grant number EC11-241). Te study was also funded by the RD16CIII/0002/0002, RD16/0025/0018, and RD16/0025/0017 projects as part of the Plan Nacional R+D+I and co-funded by ISCIII- Subdirección General de Evaluación and the Fondo Europeo de Desarrollo Regional (FEDER)Project
Gobierno de España. PI17/00657; Gobierno de España. PI17/00903; Gobierno de España. PI14CIII/00011; Gobierno de España. PI17CIII/00003; Gobierno de España. RD16CIII/0002/0002; Gobierno de España- RD16/0025/0018; Gobierno de España. RD16/0025/0017Editor's Version
https://doi.org/10.1038/s41598-019-48592-5Subjects
HIV/HCV-coinfected patients; SVR; anti-HCV antibodies; MedicinaRights
© The Author(s) 2019Abstract
The main targets for neutralizing anti-hepatitis C virus (HCV) antibodies (HCV-nAbs) are the E1 and E2
envelope glycoproteins. We have studied the characteristics of HCV-nAbs through a retrospective study
involving 29 HIV/HCV-coinfected patients who achieved sustained virological response (SVR) with pegIFNα+ribavirin anti-HCV therapy. Plasma samples at baseline and week 24 after SVR were used to
perform neutralization assays against fve JFH1-based HCV recombinant viruses coding for E1 and E2
from genotypes 1a (H77), 1b (J4), 2a (JFH1), 3a (S52) and 4a (ED43). At baseline, the majority of plasma
samples neutralized 1a, 1b, 2a, and 4a, but not 3a, genotypes. Twenty-four weeks following SVR, most
neutralizing titers declined substantially. Furthermore, titers against 3a and 2a were not detected in
many patients. Plasma samples with high HCV-nAb titers neutralized all genotypes, and the highest
titers at the starting point correlated with the highest titers at week 24 after SVR. In conclusion, high
titers of broad-spectrum HCV-nAbs were detected in HIV/HCV-coinfected individuals, however, those
titers declined soon after SVR
Files in this item
Google Scholar:Vigón, Lorena
-
Vázquez Morón, Sonia
-
Berenguer, Juan
-
González García, Juan
-
Jiménez Sousa, María Angeles
-
Guardional, Josep M.
-
Crespo, Manuel
-
Santos Gil, Ignacio de los
-
Von Wichmann, Miguel A.
-
Carrero, Ana
-
Yélamos, María Belén
-
Gómez, Julián
-
Resino, Salvador
-
Martínez, Isidoro
-
The GESIDA 3603b Cohort Study Group
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
HCV-coinfection is related to an increased HIV-1 reservoir size in cART-treated HIV patients: a cross-sectional study
López-Huertas, Maria Rosa; Palladino, Claudia; Garrido-Arquero, Marta; Esteban-Cartelle, Beatriz; Sánchez-Carrillo, Marta; Martínez-Román, Paula; Martín-Carbonero, Luz; Ryan, Pablo; Domínguez-Domínguez, Lourdes; Santos Gil, Ignacio de los; De La Fuente Moral, Sara; Benito, José Miguel; Rallón, Norma; Alcamí, José; Resino, Salvador; Fernández-Rodríguez, Amanda; Coiras, Mayte; Briz, Verónica; Ángel-Moreno, Alfonso; Bermejo-Plaza, Laura; Bisbal, Otilia; Brochado-Kith, Óscar; Castro-Álvarez, Juan Miguel; Cuevas, Guillermo; Diez-Viñas, Victorino; Gálvez-Charro, Marta; García-Fraile, Lucio; Gómez-Sanz, Alicia; Lagarde, María; Matarranz, Mariano; Mate-Cano, Irene; Mayoral-Muñoz, Mario; Muñoz-Muñoz, María; Pulido, Federico; Rubio, Rafael; Santacreu, Mireia; Sanz-Sanz, Jesús; Taveira, Nuno; Troya, Jesús; Cortegano, Isabel; Gaspar, María Luisa
2019-04-03 -
Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy
Medrano, Luz M.; Gutiérrez-Rivas, Mónica; Blanco, Julià; García, Marcial; Jiménez-Sousa, María A.; Pacheco, Yolanda M.; Montero, Marta; Iribarren, José Antonio; Bernal, Enrique; Martínez, Onofre Juan; Benito, José M.; Rallón, Norma; Resino, Salvador
2018-12-06